Search

Author/Creator Provencher, D M

1. LBA36Association of PD-L1 expression and gene expression profiling with clinical response to pembrolizumab in patients with advanced recurrent ovarian cancer: Results from the phase II KEYNOTE-100 study. (23rd October 2018)

Authors:
Ledermann, J A; Shapira-Frommer, R; Santin, A; Lisyanskaya, A S; Pignata, S; Vergote, I; Raspagliesi, F; Sonke, G S; Birrer, M J; Provencher, D M; Sehouli, J; Colombo, N; González-Martín, A; Oaknin, A; Ottevanger, P B; Rudaitis, V; Cristescu, R; Kobie, J; Ruman, J; Matulonis, U A
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer. (23rd November 2017)

Authors:
Provencher, D M; Gallagher, C J; Parulekar, W R; Ledermann, J A; Armstrong, D K; Brundage, M; Gourley, C; Romero, I; Gonzalez-Martin, A; Feeney, M; Bessette, P; Hall, M; Weberpals, J I; Hall, G; Lau, S K; Gauthier, P; Fung-Kee-Fung, M; Eisenhauer, E A; Winch, C; Tu, D
Journal:
Annals of oncology
Issue:
Volume 29:Number 2(2018)
Page Start:
431
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The contribution of germline rearrangements to the spectrum of BRCA2 mutations. Issue 9 (1st September 2006)

Authors:
Casilli, F; Tournier, I; Sinilnikova, O M; Coulet, F; Soubrier, F; Houdayer, C; Hardouin, A; Berthet, P; Sobol, H; Bourdon, V; Muller, D; Fricker, J P; Capoulade-Metay, C; Chompret, A; Nogues, C; Mazoyer, S; Chappuis, P; Maillet, P; Philippe, C; Lortholary, A
Journal:
Journal of medical genetics
Issue:
Volume 43:Issue 9(2006)
Page Start:
e49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗